Bioelectronics Corp (BIEL)

[Threepointer]

Once upon a time there was a man with a vision. His name was Andrew Whelan. He purchased an innovative device using a potentially game changing technology called pemf. He found that pemf had been used in hospitals for years as a way to decrease pain in patients. The device was the size of a small refrigerator and required patients to be in the hospital to receive treatment. Andrew realized that a miniature version could change the way people heal. His biggest hurdle was getting fda clearance, which would give the product credibility and allow him to market it to the world. His first hurdle was to get a device called actiband, which was to be used for post op eye surgery cleared. He realized that, because it was by prescription only there would be limited demand. He had the foresight to realize that he need this clearance to validate its effectiveness and also allow his dream of full musculoskeletal use to be that much closer. It wasn’t that easy. The fda, after years and millions of dollars spent by biel on research and studies, eventually fulfilled that dream. Unfortunately Andrew passed away before his dream of a successful company was realized. There have been undeniable mistakes, deals quashed as well as the ce mark inexplicably being allowed to expire. There was also dilution which resulted in this anemic share structure. Without it biel would be no more. Since andrews passing, Kelly seems to be honoring her dads dream to hopefully move the company to profitability. Oem partners have confirmed the device to be safe and effective, as these companies wouldn’t invest in “placebic junk”. They fought through a pandemic which sunk many businesses. Yet they have moved forward and are showing signs that they are moving towards profitability. There are still issues. Share structure is big. One of the first things potential investors look for in a penny stock is share count. As a result, market cap is still in he toilet. There is no way to predict what the share price will be because there are just too many factors that need improving. Those guesses lead to higher expectations, which when not met, cause panic. And that’s too bad and unreasonable.

There have been many years of opportunity to average down if one bought at 40 cents. Those who did turned out to be the wisest investors. The positive news seems to be ever increasing. Some won’t like it. Too bad.